The Cigna Group reported 2025 net income of nearly $6 billion despite grappling with rising costs of patients in the health ...

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing.

What Is It? Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a ...

Cigna Group logged higher revenue in its latest quarter as its pharmacy-benefit business Evernorth continues to grow.

Cigna (CI) stock gains as the company beats with Q4 2025 earnings and revenue even as its 2026 earnings outlook trails ...

Cigna and FTC officials said their settlement would save patients several billions of dollars on insulin drugs during the ...

Cigna remains a 'Hold' due to valuation concerns and systemic US healthcare risks despite recent sector underperformance.

Cigna ( (CI)) has held its Q4 earnings call. Read on for the main highlights of the call. Cigna’s Earnings Call Balances Growth Momentum With PBM Overhaul Risks Cigna’s latest earnings call struck a ...

By Sneha S K and Sriparna Roy Feb 5 (Reuters) - Cigna's fourth-quarter profit and revenue topped expectations, helped by ...

The settlement comes after years of meetings between NCPA and FTC staff, during which NCPA’s legal team educated government lawyers on the many egregious PBM practices that squash competition, reduce ...

Cigna Group is scheduled to report fourth-quarter results before the market opens Thursday. Here is what you need to know. NET INCOME: The healthcare company is projected to post a profit of $1.74 ...

Cigna's top brass said that the company has anticipated a "clearing event" in the pharmacy benefit management industry, and that its new model aligns with regulators' push toward greater transparency.